Early Diagnosis
Saves Lifes

Easy to use, affordable, accurate, advanced
diagnostic tests for everyone

What We Do

At BioMedomics, we use cutting-edge technology to create life saving diagnostic solutions and address global healthcare needs. Our diagnostic tests produce rapid and accurate clinical results at the point-of-care without requiring complex and expensive lab equipment-placing immediate healthcare knowledge in the hands of providers. With that knowledge comes the power to make treatment decisions and save lives.

Why We're Needed

Despite treatment availability, people in rural and remote communities still die from easily treatable diseases due to limited diagnostic testing capabilities. Mortality rates for some diseases severely affects under-resourced countries, which may lack the infrastructure to transport expensive laboratory equipment, recruit trained personnel, and supply reliable electricity. It’s a void that point-of-care diagnostic tests are designed to fill. Our diagnostic tests can be used anywhere, anytime, making it possible to provide simple, quick, accurate, and affordable clinical results to the most vulnerable members of society.

Our Solution

Products

We make point-of-care diagnostic tests which provide immediate answers to individuals and their healthcare providers wherever they are. Our innovative products are dedicated to the diagnosis of blood disorders and the identification of microorganisms and pathogens of global concern. Explore our product pages for more information.

Research & Development

BioMedomics is committed to meeting unmet maket needs by developing innovative point-of-care diagnostic technologies. We are working on ways to harness nanoparticle-based platforms, time-resolved lateral flow techniques, and novel bioconjugation processes for applications in hematology oncology, women’s health, and other areas.

Latest News

BD, BioMedomics Announce Launch of Rapid Serology Test to Detect Exposure to COVID-19

FRANKLIN LAKES, N.J. and MORRISVILLE, N.C., March 31, 2020 — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioMedomics, a privately held, North Carolina-based
Read More >

Latest FDA Guidance Allows Distribution of SARS-CoV-2 Serology Tests for Diagnostic Use

Yesterday, March 16, the FDA updated its “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency” document. The document can be downloaded
Read More >

BioMedomics develops one of the first rapid tests for COVID-19 Coronavirus

BioMedomics is the first company to publish a journal article about the development and launch of a rapid COVID-19 test.  You can also refer to
Read More >

Find Out More

Contact Info

ADDRESS

BioMedomics, Inc. 1100 Perimeter Park Drive Suite 104 Morrisville, NC 27560, USA

CALL US

+1 919.890.3070

E-MAIL

info@biomedomics.com